神经素4通过通过PI3K/AKT信号传递减少巨细胞M1极化来减轻骨关节炎
Chao Wang1, Jinjian Zheng2, Chengxin Li2
1Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Zhong Shan 2nd Road, No. 58, Guangzhou 510080, Guangdong, China; Department of Joint Surgery, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, PR China.
Cytokine
|September 20, 2025
概括
神经调节素4 (Nrg4) 向降低了促炎性M1巨细胞两极分化,减轻了骨关节炎模型中的关节损伤. 这表明Nrg4-ErbB4通路是骨关节炎治疗的潜在治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在骨关节炎 (OA) 发病和进展中,突性巨细胞极化至关重要.
- 神经调节素4 (Nrg4) 在各种炎症状况中起作用.
研究的目的:
- 通过检查它对巨细胞极化和突炎的影响,研究OA中Nrg4的治疗潜力.
- 阐明Nrg4在OA发育中的作用背后的分子机制.
主要方法:
- 在OA患者和小鼠模型中评估了Nrg4和ErbB4表达.
- 在OA模型中使用腺相关病毒5 (AAV5-Nrg4) 过度表达的Nrg4.
- 在体外用Nrg4治疗的巨细胞 (RAW264.7和BMDMs) 和使用RNA干扰 (RNAi) 抑制的ErbB4.
- 执行RNA测序 (RNA-seq) 来识别涉及的信号通路.
- 在原酶诱导的OA (CIOA) 和中介半月体 (DMM) 不稳定模型中评估关节损伤和突炎.
主要成果:
- 在OA中,Nrg4-ErbB4信号减少.
- 在体外,Nrg4治疗抑制了M1巨细胞的两极分化,并降低了促炎性基因表达.
- Nrg4通过PI3K/AKT信号通路调节巨细胞极化.
- 在OA模型中,AAV5-Nrg4注射改善了关节损伤和关节炎.
- 在体内,Nrg4抑制了M1极化,通过降低iNOS和增加CD206表达而表明.
结论:
- 在骨关节炎中,Nrg4-ErbB4轴的下调.
- 准Nrg4-ErbB4通路可以减少M1巨细胞在突组织中的极化.
- 这一途径代表了治疗骨关节炎的有希望的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


